Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
26.34
-0.53 (-1.97%)
Streaming Delayed Price
Updated: 11:27 AM EST, Nov 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Twist Bioscience Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses
↗
November 14, 2025
Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.
Via
Benzinga
Twist Bioscience Corp (NASDAQ:TWST) Stock Falls After Q4 Earnings Miss
↗
November 14, 2025
Twist Bioscience Q4 2025 earnings miss analyst estimates on revenue and EPS, triggering a sharp pre-market stock decline.
Via
Chartmill
Topics
Earnings
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
Earnings Scheduled For August 4, 2025
↗
August 04, 2025
Via
Benzinga
Preview: Twist Bioscience's Earnings
↗
August 01, 2025
Via
Benzinga
Earnings Scheduled For May 5, 2025
↗
May 05, 2025
Via
Benzinga
What's Next: Twist Bioscience's Earnings Preview
↗
May 02, 2025
Via
Benzinga
Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings
↗
November 14, 2025
Via
Benzinga
Earnings Outlook For Twist Bioscience
↗
November 13, 2025
Via
Benzinga
This Twist Bioscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
↗
November 04, 2025
Via
Benzinga
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday
↗
October 20, 2025
Via
Benzinga
Topics
Artificial Intelligence
Forecasting The Future: 6 Analyst Projections For Twist Bioscience
↗
February 04, 2025
Via
Benzinga
Cathie Wood Warns Wall Street Is Missing AI's Biggest Opportunity In Healthcare, Calling It 'Sleeper' Investment Poised For Massive Returns
↗
October 15, 2025
Cathie Wood, CEO of Ark Invest, believes healthcare is the most profound application of AI and Wall Street is overlooking its potential.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
↗
August 05, 2025
Cathie Wood-led Ark Invest executed a significant trade in Block Inc. (NYSE:XYZ) on Tuesday.
Via
Benzinga
Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings
↗
August 04, 2025
Twist Bioscience beat Q3 revenue estimates, improved gross margins, and narrowed its full-year outlook while forecasting EBITDA breakeven fiscal 2026.
Via
Benzinga
Twist Bioscience (TWST) Q3 Profit Surges
↗
August 04, 2025
Via
The Motley Fool
Twist Bioscience Corp (NASDAQ:TWST) Reports Mixed Q3 2025 Results with Revenue Miss and EPS Beat
↗
August 04, 2025
Twist Bioscience reported mixed Q3 2025 results, missing revenue estimates at $96.06M but beating EPS at -$0.47. Shares fell 5% pre-market as investors focused on the sales shortfall.
Via
Chartmill
Cathie Wood's Ark Invest Continues To Offload Coinbase, Bets Big On SoFi Technologies
↗
June 27, 2025
Cathie Wood-led Ark Invest made notable trades on Friday, including selling shares in Coinbase and Roblox.
Via
Benzinga
Cathie Wood Reiterates 'Profound' AI Application In Healthcare As Researchers Discover 'Cancer Survival Outcomes' By Facial Photograph Analysis: Here Are The Stocks That Could Benefit
↗
May 26, 2025
Cathie Wood underscored the application of AI in the healthcare sector by sharing new research by Mass General Brigham.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Says AI Innovation In Healthcare Will Be More 'Profound' Than Autonomous Taxi Networks, Humanoid Robots
↗
May 12, 2025
Cathie Wood highlights the rising applications of AI and how it is poised to impact the health care space.
Via
Benzinga
Topics
Artificial Intelligence
Where Twist Bioscience Stands With Analysts
↗
May 06, 2025
Via
Benzinga
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
↗
May 06, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
April 02, 2025
Via
Benzinga
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday
↗
March 01, 2025
Ark Invest made notable trades on Feb. 28, 2025. They purchased shares in ACHR, RXRX, TEM, and IRDM, while selling shares in TWST, ADYEY, ACCD, and EXAS.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday
↗
February 15, 2025
Cathie Wood-led Ark Invest made trades involving IRDM, TWST, PD, BEAM, ROKU, and IBTA.
Via
Benzinga
Cathie Wood Dumps $16 Million Worth Of Palantir Stock After Record Highs
↗
February 10, 2025
On Monday, February 10, 2025, the Cathie Wood-led Ark Invest sold nearly $16 million worth of Palantir shares amid a spike in the share price of the company.
Via
Benzinga
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
↗
February 08, 2025
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via
Benzinga
Earnings Scheduled For February 3, 2025
↗
February 03, 2025
Via
Benzinga
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
↗
November 29, 2024
Cathie Wood, founder and CEO of ARK Investment Management LLC, defended the future of artificial intelligence investments while highlighting Tesla Inc. as a cornerstone of technological innovation...
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
↗
November 26, 2024
Cathie Wood, CEO of ARK Invest, is doubling down on biologics, seeing unprecedented potential at the intersection of artificial intelligence, genetic sequencing, and gene editing technologies.
Via
Benzinga
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.